Abadi Lestari Indonesia Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Abadi Lestari Indonesia Tbk. trades at Rp3,730 (market cap 10.41T, 1.29M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume). The key difference: Abadi Lestari Indonesia Tbk. is far larger — about 14× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 1.29M). Which is the better fit depends on your goals.
| RLCO | RSCH | |
|---|---|---|
Market Cap | 10.41T | 742B |
Volume | 1.29M | 29.45M |
Lot | 12.9K | 294.49K |
Turnover | 4.67B | 8.14B |
Average Price | 3,617.04 | 276.35 |
Value | 4.67B | 8.14B |
Indicative Equilibrium Price | 3,730 | 270 |
Indicative Equilibrium Volume | 142 | 103 |
Trailing returns across standard periods
Latest headlines on both assets
PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.
Read more on RLCO →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →